4.6 Article

Ursolic Acid Suppresses Interleukin-17 (IL-17) Production by Selectively Antagonizing the Function of RORλt Protein

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 286, Issue 26, Pages 22707-22710

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.C111.250407

Keywords

-

Funding

  1. National Multiple Sclerosis Society (NMSS)
  2. NIH through NIAID
  3. National Institutes of Health through NICHD
  4. NHLBI
  5. National Institute of Mental Health
  6. California Institute for Regenerative Medicine
  7. Prostate Cancer Foundation
  8. Fate Therapeutics
  9. Esther B. O'Keeffe Foundation
  10. Scripps Research Institute
  11. National Institutes of Health through NIAMS
  12. Leukemia and Lymphoma, Society
  13. M.D. Anderson Cancer Center

Ask authors/readers for more resources

Th17 cells have recently emerged as a major player in inflammatory and autoimmune diseases via the production of pro-inflammatory cytokines IL-17, IL-17F, and IL-22. The differentiation of Th17 cells and the associated cytokine production is directly controlled by ROR gamma t. Here we show that ursolic acid (UA), a small molecule present in herbal medicine, selectively and effectively inhibits the function of ROR gamma t, resulting in greatly decreased IL-17 expression in both developing and differentiated Th17 cells. In addition, treatment with UA ameliorated experimental autoimmune encephalomyelitis. The results thus suggest UA as a valuable drug candidate or leading compound for developing treatments of Th17-mediated inflammatory diseases and cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available